Rezultati - Jon Rowland

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma

    Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastoma od Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto S. Pappo, Wendy B. London, Marcio H. Malogolowkin

    Izdano 2009
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma

    Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma od Marcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Zhengjia Chen, Laura C. Bowman, Marleta Reynolds, Milton J. Finegold, Brian Greffe, Jon Rowland, Kurt D. Newman, Richard B. Womer, Wendy B. London, Robert P. Castleberry

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome

    Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome od Philippe M. Campeau, Jaeseung Kim, James T. Lu, Jeremy Schwartzentruber, Omar Abdul‐Rahman, Silke Schlaubitz, David M. Murdock, Ming-Ming Jiang, Edward J. Lammer, Gregory M. Enns, William J. Rhead, Jon Rowland, Stephen P. Robertson, Valérie Cormier‐Daire, Matthew N. Bainbridge, Xiang‐Jiao Yang, Marie‐Claude Gingras, Richard A. Gibbs, David S. Rosenblatt, Jacek Majewski, Brendan Lee

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: